Pubblicazioni
scientifiche

I nostri ricercatori contribuiscono al progresso della conoscenza scientifica attraverso pubblicazioni realizzate insieme ai centri e alle università con cui collaboriamo in tutto il mondo.

Tutti Oftalmologia Diabetologia Infiammazione e Dolore Oncologia Alimentazione Farmaci Antitosse Programmi Preclinici SARS-CoV-2

Nucleic Acids Research novembre 2021

SCoV2-MD: a database for the dynamics of the SARS-CoV-2 proteome and variant impact predictions

Torrens-Fontanals, Talarico et al.

Breast Cancer Research and Treatment settembre 2021

A randomized, placebo-controlled phase 2 study of paclitaxel in combination with reparixin compared to paclitaxel alone as front-line therapy for metastatic triple-negative breast cancer (fRida)

Lori J. Goldstein, Mauro Mansutti, Christelle Levy, Jenny C. Chang, Stephanie Henry, Isaura Fernandez-Perez, Jana Prausovà, Elzbieta Staroslawska, Giuseppe Viale, Beth Butler, Susan McCanna, Pier Adelchi Ruffini, Max S. Wicha & Anne F. Schott for the fRida Trial Investigators

Cell Death & Differentiation agosto 2021

Repurposing the estrogen receptor modulator raloxifene to treat SARS-CoV-2 infection

Marcello Allegretti, Maria Candida Cesta, Mara Zippoli, Andrea Beccari, Carmine Talarico, Flavio Mantelli, Enrico M. Bucci, Laura Scorzolini & Emanuele Nicastri

Journal of Cheminformatics volume 13 luglio 2021

“Molecular Anatomy”: a new multi-dimensional hierarchical scaffold analysis tool

Manelfi C et al.

Pharmaceuticals giugno 2021

Unexpected Salt/Cocrystal Polymorphism of the Ketoprofen-Lysine System: Discovery of a New Ketoprofen-l-Lysine Salt Polymorph with Different Physicochemical and Pharmacokinetic Properties

Andrea Aramini, Gianluca Bianchini, Samuele Lillini, Simone Bordignon, Mara Tomassetti, Rubina Novelli, Simone Mattioli, Larisa Lvova, Roberto Paolesse, Michele Remo Chierotti, Marcello Allegretti

American Journal of Transplantation maggio 2021

Targeting CXCR1/2 in the first multicenter, double-blinded, randomized trial in autologous islet transplant recipients

Piotr Witkowski, Martin Wijkstrom, Piotr J. Bachul, Katherine A. Morgan, Marlon Levy, Nicholas Onaca, Sushela S. Chaidarun, Timothy Gardner, A.M. James Shapiro, Andrew Posselt, Syed A. Ahmad, Luisa Daffonchio, Pier A. Ruffini, Melena D. Bellin

Int. J. Mol. Sci. maggio 2021

Altered Local Interactions and Long-Range Communications in UK Variant (B. 1.1. 7) Spike Glycoprotein

Stefano Borocci, Carmen Cerchia, Alessandro Grottesi, Nico Sanna, Ingrid Guarnetti Prandi, Nabil Abid, Andrea R. Beccari, Giovanni Chillemi and Carmine Talarico

Science maggio 2021

X-ray screening identifies active site and allosteric inhibitors of SARS-CoV-2 main protease

Sebastian Günther et al.

Biomedicine and Pharmacotherapy aprile 2021

A new synthetic dual agonist of GPR120/GPR40 induces GLP-1 secretion and improves glucose homeostasis in mice

Gianluca Bianchini, Cecilia Nigro, Anna Sirico, Rubina Novelli, Immacolata Prevenzano, Claudia Miele, Francesco Beguino, Andrea Aramini

Biomedicines aprile 2021

Emerging Role of C5 Complement Pathway in Peripheral Neuropathies: Current Treatments and Future Perspectives

Cristina Giorgio, Mara Zippoli, Pasquale Cocchiaro, Vanessa Castelli, Giustino Varrassi, Andrea Aramini, Marcello Allegretti, Laura Brandolini and Maria Candida Cesta
Dompé logo

Dompé farmaceutici S.p.A. Socio Unico / Capitale sociale € 50.000.000,00
REA MI 289519 - Registro Imprese di Milano / Codice Fiscale e Partita IVA (VAT) IT00791570153

Chiudi